Skip to main content
. 2017 Sep 20;8(52):89707–89721. doi: 10.18632/oncotarget.21111

Figure 6. Characterization of BMI1-derived inhibition of ATR activation and ATR signalling.

Figure 6

MCF7-based EV, BMI1ΔNLS, BMI1ΔHT, BMI1ΔRF, and BMI1ΔPS stable lines have been previously established [31]. These lines were treated as indicated and examined for ATRpT1989, ATR, CHK1pS345, CHK1, actin, γH2AX, and H2AX. Experiments were performed twice. Typical images from a single repeat are shown.